Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction

Journal of Cardiology

Volumn 55, Issue 1, 2010, Pages 84-91

  Kang, Won Yu ^a   Jeong, Myung Ho ^a   Ahn, Young Keun ^a   Kim, Jong Hyun ^b   Chae, Shung Chull ^c   Kim, Young Jo ^d   Hur, Seung Ho ^e   Seong, In Whan ^f   Hong, Taek Jong ^g   Choi, Dong Hoon ^h   Cho, Myeong Chan ⁱ   Kim, Chong Jin ^j   Seung, Ki Bae ^k   Chung, Wook Sung ^k   Jang, Yang Soo ^h   Rha, Seung Woon ^l   Bae, Jang Ho ^m   Cho, Jeong Gwan ^a   Park, Seung Jung ⁿ  

^a Chonnam National University Medical School   (South Korea)

^b Busan Hanseo Hospital   (South Korea)

^c Kyungpook National University Hospital   (South Korea)

^d Young Nam University Hospital   (South Korea)

^e Keimyung University   (South Korea)

^f Chungnam National University College of Medicine   (South Korea)

^g Pusan National University School of Medicine   (South Korea)

^h Yonsei University   (South Korea)

ⁱ Chungbuk National University Hospital   (South Korea)

^j Kyung Hee University College of Medicine   (South Korea)

^k FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^l Korea University Ansan Hospital   (South Korea)

^m Konyang University   (South Korea)

ⁿ Asan Medical Center   (South Korea)

more..

Author keywords

Acute myocardial infarction; Coronary artery disease; Obesity; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KOREA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBESITY; PERCUTANEOUS CORONARY INTERVENTION; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, BALLOON; BODY MASS INDEX; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; KOREA; MALE; MYOCARDIAL INFARCTION; OBESITY; TREATMENT OUTCOME;

EID: 72449132735     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.10.004     Document Type: Article

References (25)

1. Hubert H.B., Feinleib M., McNamara P.M., and Castelli W.P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67 (1983) 968-977
2. Yusuf S., Hawken S., Ounpuu S., Bautista L., Franzosi M.G., Commerford P., Lang C.C., Rumboldt Z., Onen C.L., Lisheng L., Tanomsup S., Wangai Jr. P., Razak F., Sharma A.M., and Anand S.S. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366 (2005) 1640-1649
3. Calle E.E., Thun M.J., Petrelli J.M., Rodriguez C., and Heath Jr. C.W. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 341 (1999) 1097-1105
4. Gurm H.S., Whitlow P.L., Kip K.E., and for the BARI Investigators. The impact of body mass index on short- and long-term outcomes in patients undergoing coronary revascularization. Insights from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 39 (2002) 834-840
5. Gurm H.S., Brennan D.M., Booth J., Tcheng J.E., Lincoff A.M., and Topol E.J. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol 90 (2002) 42-45
6. Gruberg L., Weissman N.J., Waksman R., Fuchs S., Deible R., Pinnow E.E., Ahmed L.M., Kent K.M., Pichard A.D., Suddath W.O., Satler L.F., and Lindsay Jr. J. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?. J Am Coll Cardiol 39 (2002) 578-584
7. Minutello R.M., Chou E.T., Hong M.K., Bergman G., Parikh M., Iacovone F., and Wong S.C. Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry). Am J Cardiol 93 (2004) 1229-1232
8. Romero-Corral A., Montori V.M., Somers V.K., Korinek J., Thomas R.J., Allison T.G., Mookadam F., and Lopez-Jimenez F. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368 (2006) 666-678
9. Buettner H.J., Mueller C., Gick M., Ferenc M., Allgeier J., Comberg T., Werner K.D., Schindler C., and Neumann F.J. The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J 28 (2007) 1694-1701
10. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
11. Steinberg B.A., Cannon C.P., Hernandez A.F., Pan W., Peterson E.D., and Fonarow G.C. Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database. Am J Cardiol 100 (2007) 133-135
12. Franklin K., Goldberg R.J., Spencer F., Klein W., Budaj A., Brieger D., Marre M., Steg P.G., Gowda N., and Gore J.M. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med 164 (2004) 145714-145763
13. Januzzi J.L., Cannon C.P., DiBattiste P.M., Murphy S., Weintraub W., and Braunwald E. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (the TACTICS-TIMI 18 Trial). Am J Cardiol 90 (2002) 1246-1249
14. Bhatt D.L., Roe M.T., Peterson E.D., Li Y., Chen A.Y., Harrington R.A., Greenbaum A.B., Berger P.B., Cannon C.P., Cohen D.J., Gibson C.M., Saucedo J.F., Kleiman N.S., Hochman J.S., Boden W.E., et al. Utilization of early invasive management strategies for high-risk patients with non-ST segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA 292 (2004) 2096-2104
15. Bach R.G., Cannon C.P., Weintraub W.S., DiBattiste P.M., Demopoulos L.A., Anderson H.V., DeLucca P.T., Mahoney E.M., Murphy S.A., and Braunwald E. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 141 (2004) 186-195
16. Steg P.G., Iung B., Feldman L.J., Cokkinos D., Deckers J., Fox K.A., Keil U., and Maggioni A.P. Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes. Heart 88 (2002) 20-24
17. Steinberg B.A., Steg P.G., Bhatt D.L., Fonarow G.C., Zeymer U., and Cannon C.P. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry). Am J Cardiol 99 (2007) 1212-1215
18. de Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., Hall C., Cannon C.P., and Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
19. Jernberg T., Lindahl B., Siegbahn A., Andren B., Frostfeldt G., Lagerqvist B., Stridsberg M., Venge P., and Wallentin L. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol 42 (2003) 1909-1916
20. Lindahl B., Lindbäck J., Jernberg T., Johnston N., Stridsberg M., Venge P., and Wallentin L. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and Fast Revascularisation During Instability in Coronary Artery Disease (FRISC)-II substudy. J Am Coll Cardiol 45 (2005) 533-541
21. Prasad A., Stone G.W., Zimetbaum P.J., McLaughlin M., Mehran R., Garcia E., Tcheng J.E., Cox D.A., Grines C.L., Gersh B.J., and for the CADILLAC trial. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. Am Heart J 147 (2004) 669-675
22. Tespili M., Guaglium G., Valsecchi O., Musumeci G., Vassileva A., Saino A., Scuri P.M., and Gavazzi A. In-hospital clinical outcomes in elderly patients with acute myocardial infarction treated with primary angioplasty. Ital Heart J 4 (2003) 193-198
23. Nigam A., Wright R.S., Allison T.G., Williams B.A., Kopecky S.L., Reeder G.S., Murphy J.G., and Jaffe A.S. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. Int J Cardiol 110 (2006) 153-159
24. Mehta L., Devlin W., McCullough P.A., O'Neill W.W., Skelding K.A., Stone G.W., Boura J.A., and Grines C.L. Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol 99 (2007) 906-910
25. Nikolsky E., Stone G.W., Grines C.L., Cox D.A., Garcia E., Tcheng J.E., Griffin J.J., Guagliumi G., Stuckey T., Turco M., Negoita M., Lansky A.J., and Mehran R. Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction. Am Heart J 151 (2006) 168-175